Andrew Fein
Stock Analyst at H.C. Wainwright
(4.90)
# 264
Out of 4,504 analysts
1884
Total ratings
53.9%
Success rate
24.5%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MTVA MetaVia | Rated: Buy | $20 | $1.78 | +1,023.60% | 7 | Jul 9, 2026 | |
| CPRX Catalyst Pharmaceuticals | Reiterated: Buy | $32 → $30 | $31.47 | -4.67% | 65 | Jul 8, 2026 | |
| DNLI Denali Therapeutics | Reiterated: Buy | $42 | $25.68 | +63.55% | 58 | Jul 8, 2026 | |
| VRTX Vertex Pharmaceuticals | Maintained: Buy | $641 | $485.39 | +32.06% | 85 | Jul 7, 2026 | |
| BIIB Biogen | Maintained: Buy | $237 | $199.15 | +19.01% | 83 | Jul 1, 2026 | |
| ACIU AC Immune | Reiterated: Buy | $12 | $2.39 | +402.09% | 65 | Jul 1, 2026 | |
| AMLX Amylyx Pharmaceuticals | Maintained: Buy | $34 | $17.77 | +91.33% | 44 | Jul 1, 2026 | |
| BCRX BioCryst Pharmaceuticals | Maintained: Buy | $32 | $10.45 | +206.22% | 61 | Jun 30, 2026 | |
| DBVT DBV Technologies | Reiterated: Buy | $40 | $16.49 | +142.57% | 49 | Jun 30, 2026 | |
| SVRA Savara | Reiterated: Buy | $10 | $6.03 | +65.84% | 45 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $270 | $144.76 | +86.52% | 23 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $6.25 | +108.00% | 50 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $67 → $75 | $77.93 | -3.76% | 34 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $25 → $3 | $3.50 | -14.29% | 42 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $660 | $547.06 | +20.64% | 64 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $620 | $536.70 | +15.52% | 7 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $8.27 | +117.65% | 46 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ILA 3,920 | $2,124.00 | +84.56% | 44 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 | $6.97 | +29.12% | 6 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $220 | $115.61 | +90.29% | 75 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $9.24 | +224.68% | 44 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $1.61 | +210.56% | 41 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $215 | $177.11 | +21.39% | 71 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $134 | $119.35 | +12.27% | 43 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $32 | $26.22 | n/a | 66 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 → $35 | $31.38 | n/a | 29 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.63 | n/a | 17 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $14 | $5.80 | n/a | 24 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $1.73 | n/a | 46 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 → $38 | $23.42 | n/a | 11 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $14 | $2.34 | n/a | 16 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $7 | $1.90 | n/a | 20 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $11.80 | n/a | 34 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $4.88 | n/a | 27 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 → $20 | $29.73 | n/a | 24 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $5.95 | n/a | 24 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $1.09 | n/a | 21 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $4.32 | n/a | 19 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 48 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $75 | $9.68 | n/a | 27 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.06 | n/a | 16 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.72 | n/a | 27 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $40 | $1.01 | n/a | 30 | Feb 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.7553 | n/a | 21 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $14.88 | n/a | 53 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $40 → $20 | $11.81 | n/a | 18 | May 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $17.54 | n/a | 17 | Mar 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $40 | $0.745 | n/a | 14 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $2.45 | n/a | 4 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $16 | $38.87 | n/a | 8 | Mar 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.9007 | n/a | 12 | Feb 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $126 | $66.39 | n/a | 5 | Aug 12, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $5.91 | n/a | 10 | May 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $0.973 | n/a | 14 | Mar 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $0.0001 | n/a | 5 | Mar 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.93 | n/a | 3 | May 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.011 | n/a | 4 | Apr 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $57.12 | n/a | 5 | Mar 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $39.82 | n/a | 1 | Jan 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.01605 | n/a | 3 | Oct 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $0.2419 | n/a | 3 | Jun 4, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $6.98 | n/a | 1 | May 18, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $3.27 | n/a | 1 | Nov 19, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $0.000001 | n/a | 2 | Oct 3, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $3.05 | n/a | 2 | Aug 11, 2014 |
MetaVia
Jul 9, 2026
Rated: Buy
Price Target: $20
Current: $1.78
Upside: +1,023.60%
Catalyst Pharmaceuticals
Jul 8, 2026
Reiterated: Buy
Price Target: $32 → $30
Current: $31.47
Upside: -4.67%
Denali Therapeutics
Jul 8, 2026
Reiterated: Buy
Price Target: $42
Current: $25.68
Upside: +63.55%
Vertex Pharmaceuticals
Jul 7, 2026
Maintained: Buy
Price Target: $641
Current: $485.39
Upside: +32.06%
Biogen
Jul 1, 2026
Maintained: Buy
Price Target: $237
Current: $199.15
Upside: +19.01%
AC Immune
Jul 1, 2026
Reiterated: Buy
Price Target: $12
Current: $2.39
Upside: +402.09%
Amylyx Pharmaceuticals
Jul 1, 2026
Maintained: Buy
Price Target: $34
Current: $17.77
Upside: +91.33%
BioCryst Pharmaceuticals
Jun 30, 2026
Maintained: Buy
Price Target: $32
Current: $10.45
Upside: +206.22%
DBV Technologies
Jun 30, 2026
Reiterated: Buy
Price Target: $40
Current: $16.49
Upside: +142.57%
Savara
Jun 15, 2026
Reiterated: Buy
Price Target: $10
Current: $6.03
Upside: +65.84%
Jun 11, 2026
Maintained: Buy
Price Target: $270
Current: $144.76
Upside: +86.52%
Jun 11, 2026
Reiterated: Buy
Price Target: $13
Current: $6.25
Upside: +108.00%
Jun 5, 2026
Rated: Buy
Price Target: $67 → $75
Current: $77.93
Upside: -3.76%
Jun 2, 2026
Downgraded: Hold
Price Target: $25 → $3
Current: $3.50
Upside: -14.29%
May 29, 2026
Maintained: Buy
Price Target: $660
Current: $547.06
Upside: +20.64%
May 28, 2026
Reiterated: Buy
Price Target: $620
Current: $536.70
Upside: +15.52%
May 22, 2026
Maintained: Buy
Price Target: $18
Current: $8.27
Upside: +117.65%
May 14, 2026
Reiterated: Buy
Price Target: ILA 3,920
Current: $2,124.00
Upside: +84.56%
May 13, 2026
Maintained: Hold
Price Target: $9
Current: $6.97
Upside: +29.12%
May 8, 2026
Maintained: Buy
Price Target: $220
Current: $115.61
Upside: +90.29%
May 8, 2026
Maintained: Buy
Price Target: $30
Current: $9.24
Upside: +224.68%
May 8, 2026
Maintained: Buy
Price Target: $5
Current: $1.61
Upside: +210.56%
May 4, 2026
Maintained: Buy
Price Target: $215
Current: $177.11
Upside: +21.39%
May 4, 2026
Maintained: Buy
Price Target: $134
Current: $119.35
Upside: +12.27%
May 19, 2025
Reiterated: Buy
Price Target: $27 → $32
Current: $26.22
Upside: n/a
May 15, 2025
Reiterated: Buy
Price Target: $47 → $35
Current: $31.38
Upside: n/a
May 14, 2025
Rated: Hold
Price Target: n/a
Current: $2.63
Upside: n/a
May 12, 2025
Reiterated: Buy
Price Target: $20 → $14
Current: $5.80
Upside: n/a
May 9, 2025
Maintained: Buy
Price Target: $12
Current: $1.73
Upside: n/a
May 9, 2025
Reiterated: Buy
Price Target: $46 → $38
Current: $23.42
Upside: n/a
May 9, 2025
Reiterated: Buy
Price Target: $16 → $14
Current: $2.34
Upside: n/a
Apr 4, 2025
Maintained: Buy
Price Target: $8 → $7
Current: $1.90
Upside: n/a
Apr 1, 2025
Maintained: Buy
Price Target: $40
Current: $11.80
Upside: n/a
Mar 27, 2025
Maintained: Buy
Price Target: $10
Current: $4.88
Upside: n/a
Mar 17, 2025
Downgraded: Hold
Price Target: $12 → $20
Current: $29.73
Upside: n/a
Mar 7, 2025
Reiterated: Buy
Price Target: $13
Current: $5.95
Upside: n/a
Mar 6, 2025
Reiterated: Buy
Price Target: $15
Current: $1.09
Upside: n/a
Mar 5, 2025
Reiterated: Buy
Price Target: $23
Current: $4.32
Upside: n/a
Feb 28, 2025
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Feb 18, 2025
Reiterated: Buy
Price Target: $3 → $75
Current: $9.68
Upside: n/a
Feb 26, 2024
Rated: Hold
Price Target: n/a
Current: $4.06
Upside: n/a
Nov 13, 2023
Reiterated: Buy
Price Target: $10
Current: $1.72
Upside: n/a
Feb 13, 2023
Reiterated: Buy
Price Target: $100 → $40
Current: $1.01
Upside: n/a
Jan 31, 2023
Reiterated: Buy
Price Target: $3
Current: $0.7553
Upside: n/a
Oct 28, 2022
Reiterated: Hold
Price Target: $3
Current: $14.88
Upside: n/a
May 9, 2022
Reiterated: Hold
Price Target: $40 → $20
Current: $11.81
Upside: n/a
Mar 22, 2022
Maintained: Buy
Price Target: $15
Current: $17.54
Upside: n/a
Mar 16, 2022
Reiterated: Hold
Price Target: $4 → $40
Current: $0.745
Upside: n/a
Aug 14, 2020
Maintained: Buy
Price Target: $3
Current: $2.45
Upside: n/a
Mar 27, 2020
Maintained: Buy
Price Target: $18 → $16
Current: $38.87
Upside: n/a
Feb 27, 2020
Reiterated: Buy
Price Target: $7
Current: $0.9007
Upside: n/a
Aug 12, 2019
Reiterated: Buy
Price Target: $126
Current: $66.39
Upside: n/a
May 3, 2018
Maintained: Buy
Price Target: $40
Current: $5.91
Upside: n/a
Mar 16, 2018
Reiterated: Buy
Price Target: $15
Current: $0.973
Upside: n/a
Mar 6, 2018
Maintained: Buy
Price Target: $3
Current: $0.0001
Upside: n/a
May 8, 2017
Reiterated: Buy
Price Target: $8
Current: $0.93
Upside: n/a
Apr 20, 2017
Reiterated: Buy
Price Target: $4
Current: $0.011
Upside: n/a
Mar 7, 2017
Reiterated: Buy
Price Target: $18
Current: $57.12
Upside: n/a
Jan 20, 2017
Initiated Coverage: Buy
Price Target: $5
Current: $39.82
Upside: n/a
Oct 28, 2016
Reiterated: Buy
Price Target: $8
Current: $0.01605
Upside: n/a
Jun 4, 2015
Maintained: Buy
Price Target: $4
Current: $0.2419
Upside: n/a
May 18, 2015
Initiated Coverage: Buy
Price Target: $15
Current: $6.98
Upside: n/a
Nov 19, 2014
Reiterated: Buy
Price Target: $20
Current: $3.27
Upside: n/a
Oct 3, 2014
Maintained: Buy
Price Target: $9
Current: $0.000001
Upside: n/a
Aug 11, 2014
Reiterated: Buy
Price Target: $4
Current: $3.05
Upside: n/a